Alterations of brain tissue in fetal rats exposed to nicotine in utero: Possible involvement of nitric oxide and catecholamines

Neurotoxicology and Teratology

Volumn 26, Issue 1, 2004, Pages 103-112

  Önal, Aytül ^a   Uysal, Ayşegül ^a   Ülker, Sibel ^a   Delen, Yasemin ^a   Yurtseven, Mine E ^a   Evinç, Akgün ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Catecholamines; Fetus; Nicotine; Nitric oxide (NO); Pregnancy; Rat

Indexed keywords

CATECHOLAMINE; NICOTINE TARTRATE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; BRAIN WEIGHT; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; HIPPOCAMPUS; HISTOPATHOLOGY; MICROSCOPY; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; BRAIN; CATECHOLAMINES; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; FEMALE; FETUS; HIPPOCAMPUS; MALE; MICROSCOPY, ELECTRON; NICOTINE; NICOTINIC AGONISTS; NITRIC OXIDE; ORGAN SIZE; PLACENTA; PREGNANCY; PYRAMIDAL CELLS; RATS;

RATTUS NORVEGICUS;

EID: 1542345782     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2003.08.005     Document Type: Article

References (37)

1. Arbeille P., Bosc M., Vaillant M.C., Tranguart F. Nicotine-induced changes in the cerebral circulation in ovine fetus. Am. J. Perinatol. 9:1992;270-274.
2. Bell G.L., Lau K. Perinatal and neonatal issues of substance abuse. Pediatr. Clin. North. Am. 42:1995;261-281.
3. Cai Z., Hutchins J.B., Rhodes P.G. Intrauterine hypoxia-ischemia alters nitric oxide synthase expression and activity in fetal and neonatal rat brains. Brain Res. Dev. Brain Res. 109:1998;265-269.
4. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Rev. 32:2000;476-509.
5. Fedele E., Varnier G., Ansaldo M.A., Raiteri M. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmacol. 125:1998;1402-1408.
6. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60-67.
7. Green L.C., Wagner D.A., Glogowski J. Analysis of nitrate, nitrite and [N15] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
8. Joschko M.A., Dreosti I.E., Tulsi R.S. The teratogenic effects of nicotine in vitro in rats: a light and electron microscope study. Neurotoxicol. Teratol. 13:1991;307-316.
9. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha 7-neuronal receptors and neuronal CNS receptors. Brain Res. 765:1997;135-140.
10. Krishna K. Tobacco chewing in pregnancy. Br. J. Obstet. Gynaecol. 85:1978;726-728.
11. Krous H.F., Campbell G.A., Fowler M.W., Catron A.C., Farber J.P. Maternal nicotine administration and fetal brain stem damage: a rat model with implications for sudden infant death syndrome. Am. J. Obstet. Gynecol. 140:1981;743-746.
12. Kyerematen G.A., Vesell E.S. Metabolism of nicotine. Drug Metab. Rev. 23:1991;3-41.
13. Lambers D.S., Clark K.E. The maternal and fetal physiologic effects of nicotine. Semin. Perinatol. 20:1996;115-126.
14. Lee Chin J.R. Determination of the catecholamines and serotonin, their precursors tyrosine and their main metabolites in rat brain using reversed-phase high performance liquid chromatography with fluorimetric and oxidative amperometric detection in series. J. Chromatogr. 578:1992;17-30.
15. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73:1988;137-157.
16. Ma L.J., Ishizaki Y., Morita I., Murota S. Presence of nitric oxide synthase activity in the neurons of the rat embryonal cerebrum. Neurosci. Lett. 132:1991;23-25.
17. Moncada S., Palmer M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
18. Muneoka K., Ogawa T., Kamei K., Muraoka S., Tomiyoshi R., Mimura Y., Kato H., Suzuki M.R., Takigawa M. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res. Dev. Brain Res. 102:1997;117-126.
19. Naeye R.L. Cognitive and behavioral abnormalities in children whose mothers smoke cigarettes during pregnancy. J. Dev. Behav. Pediatr. 13:1992;425-428.
20. Nakata M., Anno K., Sugino N., Matsumori L.T., Nakamura Y., Kato H. Effect of intrauterine ischemia-hypoxia on endothelial nitric oxide synthase in fetal brain in rats. Biol. Neonate. 82:2002;117-121.
21. Navarro H.A., Seidler F.J., Whitmore W.L., Slotkin T.A. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J. Pharmacol. Exp. Ther. 244:1988;940-944.
22. Oliff H.S., Gallardo K.A. The effect of nicotine on developing brain catecholamine systems. Front. Biosci. 4:1999;D883-D897.
23. Pögün S., Demirgören S., Taşkiran D., Kanit L., Yilmaz O., Koylu E.O., Balkan B., London E.D. Nicotine modulates nitric oxide in rat brain. Eur. J. Neuropsychopharmacol. 10:2000;463-472.
24. Ribary U., Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J. Pharmacol. Exp. Ther. 248:1989;786-792.
25. Roy T.S., Sabherwal U. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol. Teratol. 20:1998;465-473.
26. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Nicotine evokes cell death in embryonic rat brain during neurulation. J. Pharmacol. Exp. Ther. 287:1998;1136-1144.
27. Seidler F.J., Levin E.D., Lappi S.E., Slotkin T.A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Brain Res. Dev. Brain Res. 69:1992;288-291.
28. Shimohama S., Akaike A., Kimura J. Nicotine-induced protection against glutamate cytotoxity. Nicotinic cholinergic receptor-mediated inhibition of NO formation. Ann. N.Y. Acad. Sci. 777:1996;356-361.
29. Slotkin T.A., Orband-Miller L., Queen K.L., Whitmore W.L., Seidler F.J. Effects of prenatal nicotine on biochemical development of rat brain regions: maternal infusion via osmotic mini-pumps. J. Pharmacol. Exp. Ther. 240:1987;602-611.
30. Slotkin T.A., Cho H., Whitmore W.L. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res. Bull. 18:1987;601-611.
31. Smith D.A., Hoffman A.F., David D.J., Adams C.E., Gerhardt G.A. Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci. Lett. 255:1998;127-130.
32. Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandel E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1996;1015-1023.
33. Taşkýran D., Kutay F.Z., Sözmen E., Pögün S. Sex differences in nitrite/nitrate levels and antioxidant defense in rat brain. NeuroReport. 8:1997;881-884.
34. Terada H., Nagai T., Kimura H., Kitahama K., Okada S. Distribution of nitric oxide synthase-immunoreactive neurons in fetal brains at embryonic day 15 and day 19. J. Chem. Neuroanat. 10:1996;273-278.
35. Walters J.R., Roth R.H. Effect of gammahydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem. Pharmacol. 21:1972;2111-2121.
36. Wigglesworth J.S. Fetal growth retardation in the foetal rat. Br. Med. Bull. 22:1966;13-15.
37. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.